Gelcaps

Dexocap 30/60 mg (Dexlansoprazole)

Dexocap 30/60 mg (Dexlansoprazole)

1. Product Description

  • Name: Dexlansoprazole 30mg & 60mg
  • Type: Proton Pump Inhibitor (PPI)
  • Form: Oral delayed-release capsule
  • Strength: 30 mg and 60 mg per capsule
  • Therapeutic Category: Gastrointestinal / Acid Suppression

2. Chemical Information

  • Chemical Name: Dexlansoprazole
  • Molecular Formula: C16H14F3N3O2S
  • Molecular Weight: Approximately 369.36 g/mol
  • Active Pharmaceutical Ingredient (API): Dexlansoprazole

3. Indications

  • Primary Uses:
    • Healing of erosive esophagitis associated with gastroesophageal reflux disease (GERD)
    • Maintenance of healing of erosive esophagitis and relief of associated heartburn
    • Treatment of heartburn associated with symptomatic non-erosive GERD, where approved
    • Management of acid-related gastrointestinal symptoms as directed by a healthcare professional

4. Dosage and Administration

  • Dosage Form:
    • 30 mg Capsules: Commonly used for maintenance of healing of erosive esophagitis and for symptomatic non-erosive GERD, according to the approved indication.
    • 60 mg Capsules: Commonly used for healing of erosive esophagitis, according to the approved indication.
  • Typical Dosage Schedule:
    • 30 mg: Once daily for the indication and duration specified by the prescribing information.
    • 60 mg: Once daily for the treatment period specified for erosive esophagitis.
    • Dosage and duration may vary according to the patient’s condition, age, clinical response, and applicable prescribing information.
  • Administration:
    • Take orally as directed by a healthcare professional.
    • Capsules should generally be swallowed whole with water and should not be crushed or chewed.
    • Follow the product-specific instructions regarding administration with or without food.

5. Pharmacokinetics

  • Absorption: Dexlansoprazole is absorbed following oral administration and undergoes rapid absorption.
  • Distribution: It is extensively distributed in the body and is highly bound to plasma proteins.
  • Metabolism: Primarily metabolized in the liver through oxidation and reduction pathways, including CYP2C19 and CYP3A4.
  • Excretion: Metabolites are eliminated primarily through urine and feces.

6. Side Effects

  • Common Side Effects:
    • Headache
    • Diarrhea
    • Abdominal pain
    • Nausea
    • Upper respiratory tract symptoms
  • Serious or Clinically Important Effects:
    • Severe allergic or hypersensitivity reactions
    • Severe or persistent diarrhea associated with Clostridioides difficile
    • Low magnesium levels with prolonged use
    • Vitamin B12 deficiency with prolonged treatment
    • Kidney inflammation (acute tubulointerstitial nephritis)
    • Increased risk of certain fractures with long-term use, particularly in patients with other risk factors

7. Contraindications

  • Known Allergies: Hypersensitivity to Dexlansoprazole, substituted benzimidazoles, or any component of the formulation.
  • Drug Combinations: Concomitant use with rilpivirine-containing products is contraindicated where specified by applicable prescribing information.
  • Other Contraindications: Refer to the approved product information for additional product-specific contraindications.

8. Precautions

  • Caution: Use with appropriate medical supervision in patients with liver impairment and in those requiring prolonged acid-suppression therapy.
  • Drug Interactions: Dexlansoprazole may interact with medicines whose absorption or metabolism is affected by gastric acidity or CYP-related pathways. Patients should inform their healthcare provider about all medicines and supplements they are taking.
  • Monitoring: Long-term treatment may require clinical monitoring based on patient risk factors and duration of therapy.

9. Storage

  • Conditions: Store according to the product label, generally at controlled room temperature and protected from excessive heat and moisture.
  • Packaging: Available in product-specific blister packs or bottles, depending on the manufacturer’s packaging configuration.
  • Keep Out of Reach: Keep the product out of reach of children.

10. Patient Counseling Information

Administration: Take Dexlansoprazole exactly as prescribed by your healthcare professional. Do not alter, crush, or chew the capsule unless the approved product instructions specifically permit an alternative method of administration.

Adherence: Follow the prescribed dose and duration of treatment. Do not discontinue long-term therapy without consulting your healthcare professional.

Report Symptoms: Seek medical attention for signs of a severe allergic reaction, persistent or severe diarrhea, or other unusual or serious symptoms.

Medical Advice: Inform your healthcare professional about existing medical conditions, pregnancy or breastfeeding, and all medicines or supplements being used.